ID   SPC-A1/DTX
AC   CVCL_W217
SY   SPC-A1/docetaxel
DR   Wikidata; Q54955523
RX   PubMed=22460125;
RX   PubMed=23035364;
CC   Problematic cell line: Contaminated. Parent cell line (SPC-A1) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6955 ! SPC-A1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
RX   PubMed=22460125; DOI=10.2119/molmed.2011.00230;
RA   Wang R., Huang J.-Y., Feng B., De W., Chen L.-B.;
RT   "Identification of ING4 (inhibitor of growth 4) as a modulator of
RT   docetaxel sensitivity in human lung adenocarcinoma.";
RL   Mol. Med. 18:874-886(2012).
//
RX   PubMed=23035364; DOI=10.3727/096504012X13425470196218;
RA   Song H.-Z., Yi J., Chen J., Chen L.-B.;
RT   "Nimotuzumab increases chemosensitivity of human lung adenocarcinoma
RT   cell lines to docetaxel.";
RL   Oncol. Res. 20:39-47(2012).
//